People | March 09, 2024
Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
For the full year FY25, net profit soared 12x to Rs 345 crore
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
Subscribe To Our Newsletter & Stay Updated
